Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01977339

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty

A Randomized, Double-Blinded, Control Trial to Evaluate the Efficacy of Single Injection Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia in Subjects Undergoing Unilateral Total Knee Arthroplasty

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the quality and duration of pain relief after a total knee replacement provided by a single shot of standard bupivacaine versus a single shot of liposomal bupivacaine, at the site of the femoral nerve. It is hypothesized that the liposomal bupivacaine formulation will provide more effective pain relief than standard bupivacaine.

Conditions

Interventions

TypeNameDescription
DRUGLiposome Bupivacaine10 cc of 266 mg liposome bupivacaine with 10 cc of Normal Saline
DRUGBupivacaine20 cc of 0.25% bupivacaine

Timeline

Start date
2015-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2013-11-06
Last updated
2017-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01977339. Inclusion in this directory is not an endorsement.

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty (NCT01977339) · Clinical Trials Directory